Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

An antimicrobial peptide of the cathelicidin family that provides innate immune defense by killing pathogens and modulating inflammation and wound healing.

Quick Stats
Studies 2230
Trials 95
Formula C205H340N60O53
Clear All
Utility 2
pubmed Aug 26, 2022

Evaluation of circulating serum cathelicidin levels as a potential biomarker to discriminate between active and latent tuberculosis in Uganda.

Acen. Ester Lilian EL; Kateete. David Patrick DP; Worodria. William W; Olum. Ronald R; Joloba. Moses...

The study found that people with active tuberculosis have higher levels of the natural immune peptide LL‑37 in their blood compared to those with latent infection or no infection, and that this difference can help tell the disease states apart, especially distinguishing active TB from no TB.

Utility 2
pubmed Apr 24, 2022

Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses.

Ripperda. Thomas T; Yu. Yangsheng Y; Verma. Atul A; Klug. Elizabeth E; Thurman. Michellie M; Reid. S...

Scientists used a new computer method to quickly design short proteins that can stop viruses like Ebola and COVID‑19, similar to a natural human peptide called LL‑37. The engineered peptides showed they can block the virus from entering cells, but the work is still early and not ready for personal use.

Utility 2
pubmed Sep 24, 2022

Antibacterial and anti-inflammatory properties of host defense peptides against <i>Staphylococcus aureus</i>.

Cecotto. Leonardo L; van Kessel. Kok K; Wolfert. Margreet A MA; Vogely. Charles C; van der Wal. Bart...

The study looked at three natural antimicrobial peptides—IDR-1018, CATH-2, and LL‑37—to see if they could both calm inflammation and help immune cells kill Staph aureus. All three reduced inflammatory signals, but only CATH‑2 actually stopped the bacteria from growing. IDR‑1018 made immune cells take up fewer bacteria, yet it didn’t improve killing, and overall the peptides didn’t boost the cells’ natural antibacterial power. The authors suggest mixing peptides or pairing them with antibiotics for better results.

Utility 2
pubmed Sep 6, 2022

<i>In vitro</i> Screening of Herbal Medicinal Products for Their Supportive Curing Potential in the Context of SARS-CoV-2.

Tran. Hoai Thi Thu HTT; Peterburs. Philipp P; Seibel. Jan J; Abramov-Sommariva. D D; Lamy. Evelyn E

In lab tests, a few herbal mixes used for colds (Imupret, Bronchipret thyme‑ivy, and Bronchipret thyme‑primula) showed the ability to block the virus‑spike protein from binding to the ACE2 receptor and to boost natural antimicrobial peptides like LL‑37 and immune signals such as IFN‑γ. These effects were seen only in cell cultures, not in people, so they are early clues rather than proven treatments.

Utility 2
pubmed Oct 24, 2022

Antibiofilm Activity of LL-37 Peptide and D-Amino Acids Associated with Antibiotics Used in Regenerative Endodontics on an Ex Vivo Multispecies Biofilm Model.

Pereira. Ana C C ACC; Aguiar. Alana P S APS; Araujo. Leticia M P LMP; Dantas. Larissa O LO; Mayer. M...

The study tested a natural antimicrobial peptide called LL-37, some D‑amino acids, and a common dental antibiotic mix (TAP) on a complex tooth‑root biofilm. Only the combo of LL-37 plus the antibiotics reduced bacterial numbers a little (about 1 log), while each thing alone did not work better than doing nothing.

Utility 2
pubmed Sep 30, 2022

Novel technique for rosacea treatment using optimal pulse technology: In vivo and clinical studies.

Yuan. Jiachen J; Gao. Yang Y; Pi. Longquan L; Li. Zhouna Z; Nan. Meilan M; Jin. Zhehu Z; Jin. Chengl...

A new low‑energy, three‑pulse laser treatment (AOPT‑LTL) was tested on mice with LL‑37‑induced rosacea and on 23 people with facial redness. It reduced skin inflammation, blood‑vessel changes, and the key rosacea molecules in mice, and it improved redness and flushing in patients without serious side effects.

Utility 2
pubmed Nov 4, 2022

Peptides DLL37-1 and LL37-1, an alternative to inhibit biofilm formation in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis.

Alba. Maryi Lorena Segura MLS; Dur&#xe1;n-Rodriguez. Andrea Tatiana AT; Pulido. Luz Mary Salazar LMS...

Researchers tested versions of the natural peptide LL‑37 and found that one variant, called DLL37‑1, can stop harmful bacteria like Staph aureus and Staph epidermidis from forming protective biofilms, and it does so without harming human cells in lab tests.

Utility 2
pubmed Aug 9, 2022

A Scoping Analysis of Cathelicidin in Response to Organic Dust Exposure and Related Chronic Lung Illnesses.

Golec. Marcin M; Lemieszek. Marta Kinga MK; Dutkiewicz. Jacek J; Milanowski. Janusz J; Barteit. Sand...

This review looks at how the natural peptide LL‑37 in our lungs reacts when we breathe in organic dust, which can cause diseases like asthma, COPD, and hypersensitivity pneumonitis. It finds that LL‑37 levels go up or down depending on the situation, helps fight infections and repair tissue, but can also keep inflammation going and increase mucus. Some early animal work even tried inhaling LL‑37 and saw benefits, but overall the evidence is still early and not ready for everyday use.

Utility 2
pubmed Nov 3, 2022

Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study.

Fujita. Kohei K; Ito. Yutaka Y; Yamamoto. Yuki Y; Kanai. Osamu O; Imakita. Takuma T; Oi. Issei I; It...

People with a certain lung infection called NTM are more likely to be frail and feel anxious or depressed compared to those with regular bronchiectasis. Their lungs have higher levels of the antimicrobial peptide LL‑37, but their blood levels of LL‑37 are lower, hinting at more local lung inflammation.

Utility 2
pubmed Oct 18, 2022

Preparation and Characterization of PLG Microparticles by the Multiple Emulsion Method for the Sustained Release of Proteins.

Yenying. Arphaphat A; Tangamatakul. Krissana K; Supanchart. Chayarop C; Jenvoraphot. Thannaphat T; M...

Scientists made tiny PLG particles that can slowly release proteins like a growth factor for up to two months, but when they tried the same trick with the peptide LL‑37, the results were inconsistent and hard to reproduce, meaning it’s not a ready‑to‑use method for hobbyists yet.

Utility 2
pubmed May 31, 2022

Salivary immunity of elite collegiate American football players infected with SARS-CoV-2 normalizes following isolation.

Granger. Joshua J; Cho. Eunhan E; Lindsey. Kevin K; Lemoine. Nathan N; Calvert. Derek D; Marucci. Ja...

The study looked at mouth‑immune proteins in college football players who got COVID‑19. After the usual two‑week isolation, their key antimicrobial peptide LL‑37 was back to normal, and overall saliva immunity wasn’t weakened, meaning they’re not at higher risk for other infections when they return to play.

Utility 2
pubmed Mar 29, 2023

GRK2 differentially regulates Fc&#x3b5;RI and MRGPRB2-mediated responses in mast cells.

Thapaliya. Monica M; Ali. Hydar H

The study shows that the peptide LL-37 triggers mast cells through a receptor (MRGPRB2) that isn’t turned off by the usual regulator (GRK2), unlike other triggers like compound 48/80 or substance P. Removing GRK2 in mice reduces some allergy reactions but doesn’t stop the LL-37‑driven response, suggesting LL-37 works via a different pathway.

Utility 2
pubmed Aug 29, 2022

The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin <i>in vitro</i>.

de Tapia. Lidia L; Garc&#xed;a-Fojeda. Bel&#xe9;n B; Kronqvist. Nina N; Johansson. Jan J; Casals. Cr...

The study shows that a lung protein called SP‑A (and a lab‑made piece of it) can latch onto the human antimicrobial peptide LL‑37, stopping it from hurting lung cells and causing inflammation, while still letting it kill bacteria. This means LL‑37’s harmful side‑effects can be tamed by SP‑A, but the protein isn’t something you can easily take yourself yet.

Utility 2
pubmed Aug 7, 2024

Engineering poly(dehydroalanine)-based gels <i>via</i> droplet-based microfluidics: from bulk to microspheres.

Mathews. Hannah F HF; &#xc7;eper. Tolga T; Speen. Tobias T; Bastard. C&#xe9;line C; Bulut. Selin S;...

Scientists made tiny, water‑loving gels that can hold and release the antimicrobial peptide LL‑37 depending on the pH. They showed that the size of the gel particles and how tightly they’re cross‑linked change how much peptide they can carry, and the gels are safe for cells. However, the work is about the material itself, not about how to take LL‑37 for health benefits.

Utility 2
pubmed Nov 4, 2021

In vitro activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-37, fengycin 2B, and magainin-2 against clinically important bacteria.

Denardi. Laura Bedin LB; de Arruda Trindade. Priscila P; Weiblen. Carla C; Ianiski. Lara Baccarin LB...

The study tested LL‑37 and other antimicrobial peptides against tough bacteria. LL‑37 did kill the bugs, but only at relatively high doses (40‑160 mg/L), so it’s less powerful than some other peptides tested.

Utility 2
pubmed Jul 22, 2022

The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment.

Zhang. Zhu Z; Chen. Wen-Qing WQ; Zhang. Shi-Qing SQ; Bai. Jing-Xuan JX; Lau. Ching-Lam CL; Sze. Step...

The peptide LL-37, which is part of the body’s natural antimicrobial defenses, was shown in lab dishes and mouse experiments to slow the growth of pancreatic cancer cells. It does this by creating oxidative stress, blocking a cell‑recycling process called autophagy, and shifting the tumor’s immune environment toward anti‑cancer immune cells. However, the work is still early‑stage and has not been tested in people.

Utility 2
pubmed Feb 20, 2022

Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in <i>Candida auris</i>.

Rather. Irfan A IA; Sabir. Jamal S M JSM; Asseri. Amer H AH; Ali. Sajad S

The human peptide LL-37 can kill the drug‑resistant fungus Candida auris in lab tests, especially when mixed with existing antifungal drugs, by breaking its cell membrane and stressing its cells. However, these results are only from test‑tube experiments, not human trials, so they don’t yet translate into a safe DIY treatment.

Utility 2
pubmed Dec 20, 2021

Efficacy of antimicrobial peptide LL-37 against biofilm forming Staphylococcus aureus strains obtained from chronic wound infections.

Demirci. Mehmet M; Yigin. Akin A; Demir. Cemil C

LL-37 can kill Staph bacteria from chronic wounds, but you need a lot of it (around 90‑130 mg/L) to do so. It also changes some genes that control biofilm and communication even at lower, non‑killing levels, which might help stop the sticky layers bacteria form. However, the amounts needed are high, so it’s not something you can easily use at home right now.